Vipin K. Garg

Vipin K. Garg

Chief Executive Officer at
Neostx, Inc.

Net worth: 1 M $ as of 31/05/2026

69 year
Health Technology
Commercial Services
Consumer Services

Profile

Vipin K.
Garg
is currently Chief Executive Officer & Director at Neostx, Inc. Former positions include President & Chief Executive Officer at OCERA Therapeutics LLC from 2000 to 2011, President, Chief Executive Officer & Director at Neos Therapeutics, Inc. from 2013 to 2018, President & Chief Executive Officer at Tranzyme Pharma, Inc. (Canada), President, Chief Executive Officer & Director at Altimmune, Inc. from 2018 to 2026, Director-Marketing & Technical Services at Sumitomo Pharma Co., Ltd. from 1989 to 1992, Director at The North Carolina Biotechnology Center, Principal at Sumitomo Pharma America, Inc., VP-Product Development & Manufacturing at DNX Corp., Manager-Contract Services at Bio Response, Inc. from 1986 to 1989, Chief Operating Officer at Apex Bioscience, Inc. from 1994 to 2000, and Vice President-Development at DNX Bio-Therapeutics, Inc from 1992 to 1994.
Education includes a doctorate from the University of Adelaide conferred in 1982, a graduate degree from Indian Agricultural Research Institute conferred in 1978, and an undergraduate degree from Chaudhary Charan Singh University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/01/2026 4,24,519 ( 0.22% ) 1 M $ 31/05/2026

Vipin K. Garg active positions

CompaniesPositionStart
Chief Executive Officer -

Former positions of Vipin K. Garg

CompaniesPositionEnd
ALTIMMUNE, INC. Chief Executive Officer 01/01/2026
NEOS THERAPEUTICS, INC. Chief Executive Officer 27/06/2018
OCERA THERAPEUTICS INC Chief Executive Officer 11/11/2013
Chief Operating Officer 01/01/2000
DNX Bio-Therapeutics, Inc
Corporate Officer/Principal 01/01/1994
See the detail of Vipin K. Garg's experience

Training of Vipin K. Garg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

62

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Technology Services

Consumer Services

Consumer Services

Tranzyme Pharma, Inc. (Canada)

DNX Bio-Therapeutics, Inc

Health Technology

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!